Director Lisa Johnson-Pratt Receives 8,000 Stock Options in Assembly Biosciences

This Form 4 filing reports that Lisa Johnson-Pratt, a director of Assembly Biosciences, Inc. (ASMB), was granted 8,000 stock options on June 4, 2026. The options have an exercise price of $24.11 per share and expire on June 4, 2036. According to the footnotes, these options will vest on the earlier of June 4, 2027, or the date of the company's 2027 annual meeting of stockholders, assuming continuous service. The transaction was reported by John O. Gunderson as Attorney-in-Fact on June 5, 2026. This represents a standard equity compensation award to a board member, with the options having no immediate monetary value at grant (price per share of $0) but providing future rights to purchase company stock at the set exercise price.